All lobbying firms
TARPLIN, DOWNS & YOUNG, LLC
Registrant on federal lobbying filings · filed 2025 to 2026
$30,176,000
Income reported
84
Clients represented
476
Filings counted
0
Former members lobbying
Clients
top 50 of 84
- BLUE CROSS BLUE SHIELD ASSOCIATION $660,000
- NEUROCRINE BIOSCIENCES, INC. $510,000
- SAREPTA THERAPEUTICS $510,000
- HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) $500,000
- GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) $490,000
- ABBOTT (FORMERLY KNOWN AS ALERE INC.) $480,000
- ADVAMED $480,000
- ALZHEIMER'S ASSOCIATION $480,000
- AMAZON.COM SERVICES LLC $480,000
- AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) $480,000
- AMERICAN INVESTMENT COUNCIL $480,000
- AMERICAN OSTEOPATHIC ASSOCIATION $480,000
- ASTELLAS PHARMA US, INC $480,000
- ASTRAZENECA $480,000
- AVAILITY $480,000
- BIOTECHNOLOGY INDUSTRY ORGANIZATION $480,000
- BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) $480,000
- EXCELLUS HEALTH PLAN, INC. $480,000
- FLAGSHIP PIONEERING $480,000
- FOUNDATION MEDICINE $480,000
- GILEAD SCIENCES, INC. $480,000
- JAZZ PHARMACEUTICALS INC. $480,000
- LINCARE $480,000
- LONGEVITY HEALTH PLAN $480,000
- NATIONAL SEATING & MOBILITY $480,000
- NOVOCURE INC. $480,000
- OPTION CARE HEALTH $480,000
- PHRMA $480,000
- VERTEX PHARMACEUTICALS INCORPORATED $480,000
- COTIVITI, INC. $450,000
- BOEHRINGER INGELHEIM $420,000
- BRISTOL MYERS SQUIBB $420,000
- ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) $420,000
- TRIPLE-S MANAGEMENT CORPORATION $420,000
- CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) $416,000
- AMERICAN COLLEGE OF PHYSICIANS $400,000
- LOCAL HEALTH PLANS OF CALIFORNIA $400,000
- SAS $400,000
- WHOOP $400,000
- MATHEMATICA, INC $380,000
- AMGEN INC $360,000
- AMNEAL PHARMACEUTICALS, INC. $360,000
- CRINETICS PHARMACEUTICALS $360,000
- ELI LILLY AND COMPANY $360,000
- GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) $360,000
- HANSA BIOPHARMA $360,000
- LANTHEUS $360,000
- NOVO NORDISK INC. $360,000
- QUEST DIAGNOSTICS $360,000
- SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) $360,000
Lobbyists named
11
- JENNIFER B YOUNG
- CHARLOTTE SPEARS IVANCIC
- EMILY H MURRY
- PETER FISE
- ELIZABETH T MURRAY
- RAISSA H DOWNS
- PAMELA SMITH
- PARICK BRAERTON CARROLL
- MARGARET JOSEPH
- LAURA FRIEDEL
- JEFF RECZEK
Reported by year
2 years
- 2026 $10,686,000
- 2025 $19,490,000
Issues lobbied
9
Agencies and chambers lobbied
14
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Health & Human Services, Dept of (HHS)
- White House Office
- Food & Drug Administration (FDA)
- Drug Enforcement Administration (DEA)
- Office of Management & Budget (OMB)
- Commerce, Dept of (DOC)
- Homeland Security, Dept of (DHS)
- Veterans Affairs, Dept of (VA)
- Agriculture, Dept of (USDA)
- Centers For Disease Control & Prevention (CDC)
- Health Resources & Services Administration (HRSA)
Recent filings
490 total
2A
ACTUM ON BEHALF OF HEALTHEQUITY, INC.
2A
MATHEMATICA, INC
2A
AMERICAN ACADEMY OF HOME CARE MEDICINE
2A
RAYNER SURGICAL INC.
2T
CULINA HEALTH
2TY
SWORD HEALTH, INC.
Q2
BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL)
Q2
BIOTECHNOLOGY INDUSTRY ORGANIZATION
Q2
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)
Q2
AMAZON.COM SERVICES LLC
Q2
ABBVIE INC.
Q2
JAZZ PHARMACEUTICALS INC.
Q2
ASTELLAS PHARMA US, INC
Q2
ASTELLAS PHARMA US, INC
Amended
Q2
MERCK
Q2
GILEAD SCIENCES, INC.
Q2
NOVARTIS
Q2
AMERICAN INVESTMENT COUNCIL
Q2
SAS
Q2
TERSERA THERAPEUTICS